Skip to content
Medical Health Aged Care, Women

Breast Cancer Support Arrives in Mission Beach

Breast Cancer Network Australia 2 mins read

23/10/2023

Breast Cancer Network Australia (BCNA) – Australia’s leading breast cancer consumer organisation – will be in Mission Beach tomorrow for its popular information forum, supporting locals affected by breast cancer.

BCNA’s Living Well Information Forum will cover a range of topics including current and emerging treatments, strategies to enhance physical, sexual, and emotional wellbeing, the role of allied health, and living well during treatment and beyond. 

It will also give attendees the opportunity to connect, network, share lived experiences, and understand what support and resources are available both locally and through BCNA.

Media are invited to come along between 9.00 am – 3.00 pm to cover the event.

PHOTO & INTERVIEW OPPORTUNITIES:

  • BCNA CEO, Kirsten Pilatti
  • BCNA Director of Policy, Advocacy and Support Services, Vicki Durston

Registrations for the in-person event or virtual places are FREE and open right up until the start time via the BCNA website.

 

 

Date: Tuesday 24 October

 

Location: Castaways Resort & Spa, 2 Pacific Pde, Mission Beach

 

Time: 9.00 am for 9.30 am start – 3.00 pm

 

Guest speakers:

Medical oncologist Dr Michelle White

Clinical Psychologist Chloe Oliver

Sexual Health Physician Dr Tonia Mezzini

Exercise Physiologist Jody Spicer

Physiotherapist Maebh Coleman

Breast Care Nurses Jessica Chenery and Kate Tracey 

Plus, more!

 

 

If you require quotes, content, or an interview please reach out and our team can coordinate this for you.


About us:

Breast Cancer Network Australia (BCNA) is Australia’s leading breast cancer consumer organisation. BCNA provides information and support to those diagnosed and their supporters, opportunities to connect with others going through a similar situation and work to influence a stronger healthcare system to ensure all Australians affected by breast cancer receive the very best care, treatment and support.


Contact details:

Carissa McQualter

Communications Specialist

0419 878 005

 

cmcqualter@bcna.org.au

More from this category

  • Medical Health Aged Care
  • 13/09/2024
  • 12:40
Zenas BioPharma

Zenas BioPharma Announces Pricing of Upsized Initial Public Offering

WALTHAM, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative immunology-based therapies, today announced the pricing of its upsized initial public offering of 13,235,294 shares of its common stock at an initial public offering price of $17.00 per share. All of the shares are being offered by Zenas. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses, are expected to be approximately $225.0 million. Zenas’ common stock is expected to begin trading…

  • Medical Health Aged Care
  • 13/09/2024
  • 12:31
Dementia Australia

New report reinforces dementia as chronic disease of 21st century

Updates to the Dementia in Australia report, released today by the Australian Institute of Health and Welfare (AIHW), reinforce that dementia is an urgent public health issue. Dementia is the second leading cause of death in Australia, the leading cause of death of women, the second leading cause of disease burden overall, and the leading cause of burden for people aged 65 and over. Dementia Australia CEO Professor Tanya Buchanan saidthe report highlights the enormity and impact of dementia in Australia as the chronic disease of the 21st century. “Despite the growing number of Australians diagnosed with dementia – there…

  • Medical Health Aged Care, Science
  • 13/09/2024
  • 11:08
La Trobe University

Centre to play key role in global AI medical research

Artificial intelligence promises to unlock new cures for cancer and other diseases by revolutionising the speed, cost and availability of personally designed drugs and enabling these to be tested on “digital twins" before being given to patients. AI will enable broad-spectrum like chemotherapy to be replaced by these more personalised, better targeted treatments. Scientists at La Trobe University's new Australian Centre for Artificial Intelligence in Medical Innovation (ACAMI), launched today, will also apply AI techniques to mRNA therapy development to enable faster design of more precise and effective treatments. Vice-Chancellor Professor Theo Farrell said ACAMI would sit within La Trobe’s…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.